Brain Metastasis after a Gastrectomy for Gastric Cancer

위암의 근치적 절제 후 발생한 뇌 전이

  • Kim, Yong-Il (Department of Surgery, National Health Insurance Corporation Ilsan Hospital) ;
  • Lee, Jun-Ho (Department of Surgery, Yonsei University College of Medicine) ;
  • Yun, Seong-Hyeon (Department of Surgery, National Health Insurance Corporation Ilsan Hospital) ;
  • Noh, Sung-Hoon (Department of Surgery, Yonsei University College of Medicine) ;
  • Min, Jin-Sik (Department of Surgery, Yonsei University College of Medicine)
  • 김용일 (국민건강보험공단 일산병원 외과) ;
  • 이준호 (연세대학교 의과대학 외과학교실) ;
  • 윤성현 (국민건강보험공단 일산병원 외과) ;
  • 노성훈 (연세대학교 의과대학 외과학교실) ;
  • 민진식 (연세대학교 의과대학 외과학교실)
  • Published : 2001.06.01

Abstract

Purpose: The common features of brain metastases from gastric cancer are unknown because brain metastasis is an uncommon pattern of metastasis. The purpose of this study was to investigate the clinical features of and the prognosis for patients with brain metastases after a curative resection for gastric cancer. Materials and Methods: Twenty-one (21) cases of patients with brain metastases of gastric cancer, who had been treated at the Department of Surgery, Yonsei University College of Medicine, were assessed retrospectively. Results: The mean age was $55.8\pm9.6$ years (range: $34\~70$ years), and the male-to-female ratio was 2.5 : .1. The most common neurologic symptom was headache ($38.5\%$), and no patient was free from the neurologic symptoms. The incidence of parenchymal metastasis (PM: $76.2\%$) was higher than that of leptomeningeal metastasis (LM: $19.0\%$). Patients with gastric cancer and brain metastasis showed high rates of blood and lymphatic vessel invasion (lymphatic vessel invasion: $85.7\%$; blood vessel invasion: $80.9\%$). According to Lauren's classification, the incidence of intestinal types was 14/21 ($66.7\%$), that of diffuse types was 3/21 ($14.3\%$) and that of mixed types was 4/21 ($19.0\%$). The mean interval between the gastrectomy and the diagnosis of brain metastasis was $24.7\pm4.0$ months (PM: 26.8 months; LM: 20.3 months). The median period of survival after diagnosis of brain metastasis was 2 months for paren chymal metastasis and 0 months for leptomeningeal metastasis. Conclusion:.. During a follow-up period, patients with neurologic symptoms should be suspected of having brain metastasis. Early diagnosis and treatment is the only hope to prolong survival in such patients.

Keywords